hiv-1 gag dna
Vaccineexperimental
Clinical trial activity
3 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 23, 2005 (NCT00111605)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hiv-1 gag dna
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00195312 | Phase 1 | Aug 1, 2005 | Pfizer, Wyeth |
| NCT00115960 | Phase 1 | Jun 26, 2005 | Harvard University, National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00111605 | Phase 1 | May 23, 2005 | National Institute of Allergy and Infectious Diseases (NIAID), University of Alabama, Birmingham, Vanderbilt University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2005 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Pfizer | For profit | 1 | 1 | 1 | 2005 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Wyeth | For profit | 1 | 0 | 1 | 2005 |
7 organizations
Page 1 / 1